Vitrafy Life Sciences Ltd. ASX: VFY Share Price & Review

VFY Overview

VFY Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About VFY

Website

N/A

Telephone

61.3.4331.9974

Address

Suite 2, Level 11 385 Bourke Street Melbourne, Victoria (VIC) 3000

Description

N/A

VFY Price Chart

Key Stats

Market Cap

n/a

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.08 - 2.1

Trade Value (12mth)

AU$12,362.00

1 week

1 month

6.67%

YTD

-8.57%

1 year

All time high

2.10

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

11-Aug-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

VFY Announcements

Latest Announcements

Date	Announcements
05 August 25	FY25 Full Year Results Presentation - Amended × FY25 Full Year Results Presentation - Amended
05 August 25	FY25 Corporate Governance Statement × FY25 Corporate Governance Statement
05 August 25	FY25 Appendix 4G × FY25 Appendix 4G
05 August 25	FY25 Full Year Results Presentation × FY25 Full Year Results Presentation
05 August 25	FY25 Appendix 4E and Annual Report × FY25 Appendix 4E and Annual Report
05 August 25	Leadership Transition at Vitrafy × Leadership Transition at Vitrafy
31 July 25	Expiry of Voluntary Escrow Restrictions × Expiry of Voluntary Escrow Restrictions
30 July 25	Q4 FY25 Quarterly Activities Report and Appendix 4C × Q4 FY25 Quarterly Activities Report and Appendix 4C
29 July 25	Appendix 4C, FY25 Annual Results and Investor Call Schedule × Appendix 4C, FY25 Annual Results and Investor Call Schedule
25 June 25	Notification of cessation of securities - VFY × Notification of cessation of securities - VFY
30 May 25	Change of Address × Change of Address
15 May 25	Application for quotation of securities - VFY × Application for quotation of securities - VFY
02 May 25	Vitrafy Q3 FY25 Investor Presentation × Vitrafy Q3 FY25 Investor Presentation
02 May 25	Release of Securities from Mandatory Escrow × Release of Securities from Mandatory Escrow
29 April 25	Q3 FY25 Quarterly Activities Report and Appendix 4C × Q3 FY25 Quarterly Activities Report and Appendix 4C
28 April 25	Vitrafy Q3 FY25 Investor Briefing × Vitrafy Q3 FY25 Investor Briefing
16 April 25	USAISR successful Phase 1 Blood Platelet study × USAISR successful Phase 1 Blood Platelet study
15 April 25	Notification regarding unquoted securities - VFY × Notification regarding unquoted securities - VFY
08 April 25	Application for quotation of securities - VFY × Application for quotation of securities - VFY
27 March 25	Release of Securities from Mandatory Escrow × Release of Securities from Mandatory Escrow
20 March 25	NWR Virtual Healthcare Conference Presentation × NWR Virtual Healthcare Conference Presentation
19 March 25	Vitrafy to present at NWR Virtual Healthcare Conference × Vitrafy to present at NWR Virtual Healthcare Conference
19 March 25	Change of Director's Interest Notice × Change of Director's Interest Notice
18 March 25	Vitrafy Awarded Industry Growth Program Grant × Vitrafy Awarded Industry Growth Program Grant
28 February 25	Notification of cessation of securities - VFY × Notification of cessation of securities - VFY

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Falling Divs over next 2

Values and Recommendations

Key Stats

Consensus Score

Recommendation

EPS 1 month Change

Quality Yield

Falling Divs over next 2

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

VFY Shortsell

Frequently Asked Questions

What is the current share price of Vitrafy Life Sciences Ltd. (VFY:ASX)?

The current share price of Vitrafy Life Sciences Ltd. (VFY:ASX) is AU$1.6.

What is the 52-week high share price for Vitrafy Life Sciences Ltd. (VFY:ASX)?

The 52-week high share price for Vitrafy Life Sciences Ltd. (VFY:ASX) is AU$2.10.

What is the 52-week low share price for Vitrafy Life Sciences Ltd. (VFY:ASX)?

The 52-week low share price for Vitrafy Life Sciences Ltd. (VFY:ASX)? is AU$1.08.

What is the dividend yield for Vitrafy Life Sciences Ltd. (VFY:ASX)?

Vitrafy Life Sciences Ltd. (VFY:ASX) does not pay a dividend.

What was Vitrafy Life Sciences Ltd. (VFY:ASX) last dividend payment?

Vitrafy Life Sciences Ltd. (VFY:ASX) does not pay a dividend.

What is the franking level for Vitrafy Life Sciences Ltd. (VFY:ASX)?

Vitrafy Life Sciences Ltd. (VFY:ASX) has a franking level of 0.0%.

In which sector is Vitrafy Life Sciences Ltd. (VFY:ASX) classified?

Vitrafy Life Sciences Ltd. (VFY:ASX) is classified in the Healthcare.